质母细胞瘤免疫疗法的研究热点和趋势:图书统计和视觉分析
Keren Lv1, Xue Du2, Chunbao Chen3
1Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Frontiers in oncology
|August 23, 2024
概括
这项研究分析了质母细胞瘤 (GBM) 免疫治疗研究趋势. 美国在出版物方面处于领先地位,突出显示免疫疗法.
科学领域:
- 质母细胞瘤 (GBM) 研究
- 中枢神经系统 (CNS) 瘤
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 质母细胞瘤 (GBM) 是一种有侵略性的中枢神经系统恶性瘤,预后不佳,复发率高.
- 免疫逃脱与GBM瘤发生有关,将免疫疗法定位为关键的补充治疗.
- 对GBM的免疫疗法是一个快速增长的研究领域.
研究的目的:
- 想象和分析GBM免疫疗法研究的科学成果和新兴趋势.
- 确定该领域的关键贡献者,出版物和研究集群.
主要方法:
- 来自Web of Science核心集合 (WOScc) 的1613个出版物的图书统计和视觉分析.
- 使用CiteSpace,R软件和一个在线文献计量平台.
- 分析重点是国家,作者,机构,期刊,参考文献和关键词.
主要成果:
- 美国是主要的出版商 (44.45%),其次是中国 (17.55%),具有强大的国际合作.
- 杜克大学和哈佛医学院是顶级机构;OHN H SAMPSON和MICHAEL LIM是多产的作者.
- 免疫学领域的边界出版最多,而临床癌症研究获得了最多的共同引用.
结论:
- 免疫疗法是质母细胞瘤的重要和不断发展的治疗策略.
- 加强国际和机构合作对于推动GBM免疫疗法研究至关重要.
- 免疫疗法是目前和未来质母细胞瘤治疗策略的关键重点.
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K